Partner's Blog - October 2019
The Corporate Affiliates Program provides an exciting opportunity for companies to support the work of the American Society of Transplantation (AST) and receive tangible benefits throughout the year. The following companies are members of the 2019 Corporate Affiliate Program (CAP):
What's News With Our Partners:
- Atara Biotherapeutics is investigating Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD). Please click here to learn more about the currently enrolling Phase 3 clinical study ‘ALLELE’ in Solid Organ Transplant-associated PTLD or click here to learn more about the currently enrolling Phase 3 clinical study ‘MATCH’ in Hematopoietic Stem Cell Transplant-associated PTLD.
- We are pleased to share that the availability of ENVARSUS XR is unaffected by the current shortage on generic immediate-release tacrolimus capsules (FDA Website).
- Viracor LabAlert – The Mobile App for Healthcare Providers
You work hard to diagnose your patients. We’re making it easy to get test results.
Securely view patients’ samples status, get notifications when results are available, access current and historical lab reports, view Viracor’s test directory, and learn more about our testing.
Download the mobile app here.
Check out all of our CAP partners:
